Anti-beta-receptor antibodies in human dilated cardiomyopathy and correlation with HLA-DR antigens

• Published in: The American journal of cardiology Vol. 65; no. 7; pp. 483 - 487
• Main Authors: Limas, Constantinos J., Limas, Catherine, Kubo, Spencer H., Olivari, Maria Teresa
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 15.02.1990
• Subjects: Autoantibodies - immunology; Cardiomyopathy, Alcoholic - immunology; Cardiomyopathy, Dilated - genetics; Cardiomyopathy, Dilated - immunology; Female; Histocompatibility Testing; HLA-DR Antigens - immunology; HLA-DR4 Antigen - immunology; Humans; Immunoblotting; Male; Middle Aged; Precipitin Tests; Radioligand Assay; Receptors, Adrenergic, beta - immunology
• ISSN: 0002-9149; 1879-1913
• DOI: 10.1016/0002-9149(90)90815-I

The mechanisms responsible for the decline in the density of β-adrenoceptors in the failing myocardium have not been adequately defined. It is a possibility that the nature of the process leading to heart failure may determine, in large part, the pathogenesis of this decline. Sera of some patients with dilated cardiomyopathy contain antibodies directed against the β-adrenoceptor, as judged by ligand binding inhibition, immunoprecipitation and immunoblotting assays. Because deranged immune function is thought to play a role in dilated cardiomyopathy, immunogenetic markers of the propensity to develop anti-β-receptor antibodies were sought. The prevalence of HLA-DR4 was significantly higher in dilated cardiomyopathy patients (40 vs 24% in 511 normal subjects, p c < 0.001). In contrast, no association was found between HLA phenotypes and alcoholic cardiomyopathy. Furthermore, 72% (13 of 18) of the HLA-DR4 dilated cardiomyopathy patients had anti-β-receptor antibodies compared to 22% (7 of 33) HLA-DR4-negative patients; in the latter, presence of antibody was linked to the HLA-DR1 phenotype. Conversely, 67% (15 of 23) of the antibody-positive patients were typed as HLA-DR4 compared to only 10% of the antibody-negative patients. Interestingly, none of the 23 antibody-positive patients were typed as HLA-DR3 while 37% of the antibody-negative did. Only 25% of alcoholic cardiomyopathy patients had anti-β-receptor antibodies and no preponderant HLA association could be demonstrated. These results suggest that the presence of anti-β-receptor antibodies in patients with idiopathic dilated cardiomyopathy may be under the control of the major histocompatibility locus.